跳至主要内容
临床试验/NCT02298309
NCT02298309已完成不适用

Test and Treat TB: A Proof of Concept Trial in South Africa

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 4,815 人开始时间: 2015年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
4,815
试验地点
1
主要终点
Number of patients who complete tuberculosis treatment

研究概览

简要总结

The purpose of this study is (1) to establish the feasibility, yield, and clinical impact of a "Test & Treat TB" strategy on a mobile HIV screening unit in South Africa and (2) to assess the cost and cost-effectiveness of this mobile, integrated HIV/TB screening strategy for maximizing linkage to TB care and treatment completion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English or Zulu speaking
  • presenting for screening at mobile unit
  • voluntarily undergoing HIV testing
  • able and willing to give informed consent
  • willing to share HIV and TB test results
  • willing to attend one of six local clinics for treatment
  • access to a mobile phone

排除标准

  • 未提供

研究组 & 干预措施

Usual Care

No Intervention

Patients in the usual care arm will be screened for tuberculosis (TB) on a mobile unit and referred for treatment according to the current standard of care in South Africa

Test-and-Treat Intervention

Active Comparator

Patients in the intervention arm will partake in a Test-and-Treat TB strategy involving mobile GeneXpert MTB/RIF testing, facilitated TB treatment initiation, SMS reminders for clinic visits, and cashless incentives.

干预措施: Test-and-Treat TB (Other)

结局指标

主要结局

Number of patients who complete tuberculosis treatment

时间窗: 6 months

次要结局

  • Proportion of mobile testers screened for tuberculosis(20 months)
  • Prevalence of tuberculosis and rifampin resistance(20 months)
  • Prevalence of TB among those tested(20 months)
  • ART initiation date as documented by clinic record for those HIV co-infected(6 months)
  • Distribution of TB symptoms ascertained from TB symptom screen questionnaire(20 months)
  • Proportion of eligible participants able to produce sputum samples(20 months)
  • Proportion returning to the mobile tester for TB test result(20 months)
  • Linkage to TB care (first visit to a local TB treatment site ascertained from clinic record)(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ingrid V. Bassett, MD, MPH

Associate Professor of Medicine

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验